IPAbenzinga

ImmunoPrecise Antibodies CEO Jennifer Bath And BioStrand Co-Founders Dirk Van Hyfte And Ingrid Brands Collectively Acquired A Total Of 763,120 Shares Of IPA On The Open Market For An Aggregate Amount Of $306,000

Summary

No summary available.

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on December 23, 2024 by benzinga